B·R·A·H·M·S Biomarkers: Preeclampsia Management Resources

Explore resources: B·R·A·H·M·S Biomarkers for preeclampsia screening

Discover an extensive library of resources to learn more about B·R·A·H·M·S Biomarkers for preeclampsia screening and the benefits of implementing these assays into your laboratory.

Customer and patient stories

Webinars and symposiums

Dr. Champa Woodham and Dr. Rebecca Khan discuss the biomarker blood test for preeclampsia risk assessment.

Preeclampsia Risk Assessment using Angiogenic Biomarkers in Hospitalized Patients – Dr. Sarosh Rana, MD, MPH and Dr. Ananth Karumanchi, MD

Understanding the Challenges in Diagnosis and Implications on Women's Health – Rebecca Khan, MD, FACOG, Veena Joy, MSc, PhD, and Jessica Murphy, MLS(ASCP)CM

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.

 

© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.

 

KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.